Lineage Cell Therapeutics, Inc. (LCTX) quarterly income statement — complete revenue, gross profit & net income history
Lineage Cell Therapeutics, Inc. (LCTX) annual income statement — 30-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 1.07M | 1.73M | 6.61M | 3.68M | 2.77M | 1.5M | 2.87M | 3.78M | 1.41M | 1.44M | 2.09M | 1.25M | 3.23M | 2.39M | 1.92M | 3M | 4.55M | 5.24M | 960K | 2.2M |
| Revenue Growth % | -61.34% | 14.85% | 130.4% | -2.59% | 96.38% | 4.02% | 37.36% | 203.29% | -56.34% | -39.48% | 9.03% | -58.44% | -29.17% | -54.44% | 99.48% | 36.15% | 932.43% | 1687.37% | 478.31% | 543.86% |
| Cost of Goods Sold | 0 | 188K | 66K | 5K | 39K | 36K | 154K | 38K | 44K | 273K | 431K | 169K | 127K | 119K | 102K | 235K | 215K | 176K | 204K | 985K |
| COGS % of Revenue | - | 10.9% | 1% | 0.14% | 1.41% | 2.4% | 5.37% | 1.01% | 3.13% | 18.91% | 20.64% | 13.56% | 3.94% | 4.99% | 5.33% | 7.84% | 4.72% | 3.36% | 21.25% | 44.73% |
| Gross Profit | 1.07M | 1.54M | 6.54M | 3.68M | 2.73M | 1.47M | 2.71M | 3.74M | 1.36M | 1.17M | 1.66M | 1.08M | 3.1M | 2.27M | 1.81M | 2.76M | 4.34M | 5.06M | 756K | 1.22M |
| Gross Margin % | 100% | 89.1% | 99% | 99.86% | 98.59% | 97.6% | 94.63% | 98.99% | 96.88% | 81.09% | 79.36% | 86.44% | 96.06% | 95.01% | 94.67% | 92.16% | 95.28% | 96.64% | 78.75% | 55.27% |
| Gross Profit Growth % | -60.78% | 4.84% | 141.05% | -1.74% | 99.85% | 25.19% | 63.79% | 247.35% | -55.97% | -48.35% | -8.6% | -61.02% | -28.58% | -55.21% | 139.81% | 127.03% | 1272.78% | 2696.13% | 1353.85% | 407.08% |
| Operating Expenses | 9.99M | 9.13M | 13.09M | 7.46M | 22.51M | 7.97M | 7.82M | 7.58M | 7.23M | 7.83M | 8.02M | 7.78M | 8.12M | 8.91M | 8.45M | 8.01M | 8.57M | 11.46M | 28.99M | 8.06M |
| OpEx % of Revenue | 934.71% | 529.28% | 198.09% | 202.72% | 813.96% | 530.69% | 272.8% | 200.61% | 513.57% | 542.38% | 384.05% | 624.56% | 251.84% | 373.39% | 441.36% | 267.31% | 188.27% | 218.77% | 3020.21% | 366.03% |
| Selling, General & Admin | 5.22M | 5.08M | 4.85M | 4.19M | 4.56M | 4.86M | 4.4M | 4.41M | 4.36M | 4.84M | 4.14M | 4.04M | 4.25M | 4.72M | 4.35M | 4.42M | 5.27M | 8.47M | 4.42M | 5.32M |
| SG&A % of Revenue | 488.12% | 294.72% | 73.43% | 113.85% | 164.92% | 323.37% | 153.45% | 116.7% | 309.87% | 335.46% | 198.52% | 324.32% | 131.75% | 197.99% | 227.05% | 147.5% | 115.75% | 161.71% | 460.83% | 241.46% |
| Research & Development | 4.77M | 4.23M | 8.24M | 3.27M | 3.11M | 3.11M | 3.42M | 3.17M | 2.87M | 2.99M | 3.87M | 3.74M | 3.87M | 4.18M | 4.1M | 3.59M | 3.3M | 2.99M | 24.78M | 2.81M |
| R&D % of Revenue | 446.59% | 245.45% | 124.67% | 88.86% | 112.33% | 207.32% | 119.35% | 83.91% | 203.69% | 206.93% | 185.54% | 300.24% | 120.09% | 175.4% | 214.31% | 119.81% | 72.52% | 57.06% | 2581.04% | 127.66% |
| Other Operating Expenses | 0 | -188K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -208K | -68K |
| Operating Income | -8.92M | -7.59M | -6.55M | -3.79M | -19.78M | -6.5M | -5.11M | -3.84M | -5.87M | -6.66M | -6.36M | -6.71M | -5.02M | -6.64M | -6.64M | -5.25M | -4.23M | -6.4M | -28.24M | -6.84M |
| Operating Margin % | -834.71% | -440.17% | -99.09% | -102.85% | -715.37% | -433.09% | -178.17% | -101.61% | -416.69% | -461.29% | -304.69% | -538.12% | -155.78% | -278.37% | -346.68% | -175.15% | -92.99% | -122.13% | -2941.46% | -310.76% |
| Operating Income Growth % | 54.89% | -16.73% | -28.14% | 1.41% | -237.14% | 2.34% | 19.68% | 42.73% | -16.78% | -0.29% | 4.17% | -27.69% | -18.66% | -3.85% | 76.49% | 23.26% | 40.2% | 9.28% | -380.07% | -1.75% |
| EBITDA | 1.54M | -7.41M | -6.36M | -3.61M | -19.61M | -6.34M | -4.96M | -3.7M | -5.72M | -6.49M | -6.19M | -6.53M | -4.85M | -6.47M | -6.47M | -5.06M | -4.05M | -6.22M | -28.05M | -6.64M |
| EBITDA Margin % | 144.43% | -429.28% | -96.28% | -98.02% | -709.19% | -422.17% | -172.91% | -97.88% | -406.61% | -449.17% | -296.31% | -524% | -150.51% | -271.21% | -337.65% | -168.71% | -88.97% | -118.73% | -2921.56% | -301.73% |
| EBITDA Growth % | 107.87% | -16.78% | -28.29% | 2.46% | -242.52% | 2.24% | 19.85% | 43.35% | -17.94% | -0.23% | 4.31% | -29.08% | -19.82% | -4.07% | 76.95% | 23.87% | 41.14% | 8.07% | -405.72% | -5.86% |
| D&A (Non-Cash Add-back) | 0 | 188K | 186K | 178K | 171K | 164K | 151K | 141K | 142K | 175K | 175K | 176K | 170K | 171K | 173K | 193K | 183K | 178K | 191K | 199K |
| EBIT | 1.54M | -4.79M | -4.39M | -29.75M | -4.94M | -4.14M | -3.25M | -3M | -5.77M | -6.56M | -6.36M | -6.71M | -5.02M | -6.64M | -6.64M | -5.25M | -4.23M | -6.4M | -28.24M | -6.84M |
| Net Interest Income | 378K | 405K | 393K | 366K | 454K | 478K | 393K | 397K | 463K | 462K | 404K | 433K | 382K | 410K | 394K | 384K | 51K | 1K | 3K | 1K |
| Interest Income | 378K | 405K | 393K | 366K | 454K | 478K | 393K | 397K | 463K | 462K | 404K | 433K | 382K | 410K | 394K | 384K | 51K | 1K | 3K | 1K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Other Income/Expense | 10.47M | 2.8M | 2.16M | -25.97M | -10.58M | 2.36M | 1.86M | 839K | 94K | 103K | 1.65M | -453K | -179K | 435K | 277K | -324K | -2.55M | -697K | 229K | -2M |
| Pretax Income | 1.54M | -4.79M | -4.39M | -29.75M | -30.36M | -4.14M | -3.25M | -3M | -5.77M | -6.56M | -4.71M | -7.16M | -5.2M | -6.21M | -6.36M | -5.58M | -6.78M | -7.09M | -28.01M | -8.85M |
| Pretax Margin % | 144.43% | -277.62% | -66.4% | -808.26% | -1098.16% | -275.83% | -113.32% | -79.41% | -410.01% | -454.16% | -225.77% | -574.48% | -161.33% | -260.14% | -332.22% | -185.96% | -148.96% | -135.44% | -2917.6% | -401.73% |
| Income Tax | 0 | 0 | -5.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.8M | 0 | 541K | 0 | 0 | 1.18M | -1.01M |
| Effective Tax Rate % | 0% | 0% | 120.33% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 29.05% | 0% | -9.7% | 0% | 0% | -4.22% | 11.44% |
| Net Income | 1.48M | -4.81M | 851K | -29.78M | -30.46M | -4.14M | -3.27M | -3.03M | -5.76M | -6.54M | -4.78M | -7.11M | -5.23M | -4.37M | -6.35M | -6.07M | -6.76M | -7.09M | -28.99M | -7.82M |
| Net Margin % | 138.63% | -278.96% | 12.88% | -809.05% | -1101.77% | -275.57% | -114.12% | -80.29% | -409.09% | -453.05% | -228.69% | -570.63% | -162.14% | -183.24% | -331.8% | -202.44% | -148.54% | -135.33% | -3019.79% | -355.27% |
| Net Income Growth % | 104.86% | -16.26% | 126% | -881.58% | -428.89% | 36.73% | 31.46% | 57.33% | -10.15% | -49.63% | 24.85% | -17.15% | 22.68% | 38.31% | 78.08% | 22.42% | -41.25% | -400.49% | -1526.67% | -0.81% |
| Net Income (Continuing) | 1.54M | -4.79M | 892K | -29.75M | -30.36M | -4.14M | -3.25M | -3M | -5.77M | -6.56M | -4.71M | -7.16M | -5.2M | -4.4M | -6.36M | -6.12M | -6.78M | -7.09M | -29.19M | -7.83M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | -1.18M | -1.2M | -1.24M | -1.27M | -1.37M | -1.37M | -1.39M | -1.43M | -1.41M | -1.4M | -1.46M | -1.41M | -1.44M | -1.4M | -1.4M | -1.35M | -1.33M | -1.32M | -1.12M |
| EPS (Diluted) | -0.03 | -0.02 | 0.00 | -0.13 | -0.13 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -0.06 | -0.05 | -0.17 | -0.05 |
| EPS Growth % | 76.92% | -7.1% | 121.47% | -707.45% | -326.23% | 48.88% | 41.16% | 60.44% | 0.65% | -38.22% | 28.61% | -13.06% | 47.7% | 47.03% | 77.18% | 22.91% | -99.66% | - | -1359.26% | 9.67% |
| EPS (Basic) | 0.01 | -0.02 | 0.00 | -0.13 | -0.13 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -0.06 | -0.05 | -0.17 | -0.05 |
| Diluted Shares Outstanding | 261.47M | 261.18M | 230.12M | 228.85M | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.73M | 169.65M | 167.62M | 167.62M |
| Basic Shares Outstanding | 249.5M | 245.03M | 230.12M | 228.85M | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.07M | 169.65M | 167.62M | 167.62M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |